Published in Gut on September 01, 1988
RELEASE OF A KININ PEPTIDE IN THE CARCINOID SYNDROME. Lancet (1964) 3.74
Urinary prostaglandins. Identification and origin. J Clin Invest (1975) 3.07
Prostaglandins in amine-peptide-secreting tumours. Lancet (1968) 2.75
Effect of orally administered prostaglandin E1 on gastric secretion and gastrointestinal motility in man. Gut (1968) 2.09
Pharmacologic and endocrine aspects of carcinoid syndrome. Adv Pharmacol (1967) 1.74
Prostaglandins from tumours of human large bowel. Br J Cancer (1977) 1.58
Bradykinin-stimulated electrolyte secretion in rabbit and guinea pig intestine. Involvement of arachidonic acid metabolites. J Clin Invest (1983) 1.45
The effect of 16,16-dimethyl prostaglandin E2 on meal-stimulated gastric acid secretion and serum gastrin in duodenal ulcer patients. Gastroenterology (1976) 1.37
Human blood prostaglandins: formation during clotting. Prostaglandins (1972) 1.35
Double-blind clinical trial on gastroduodenal ulcer healing with prostaglandin E2 analogues. Gut (1977) 1.26
Radioimmunoassay techniques for the determination of the local release of prostaglandins and thromboxanes. J Pharmacol Methods (1982) 1.22
Further observations on the endocrine aspects of argentaffinoma. Scott Med J (1957) 1.21
Influence of long-term 16,16-dimethyl prostaglandin E2 treatment on the rat gastrointestinal mucosa. Gastroenterology (1983) 1.16
Prostaglandin E2 biosynthesis by rabbit renomedullary interstitial cells in tissue culture. Mechanism of stimulation by angiotensin II, bradykinin, and arginine vasopressin. J Biol Chem (1977) 1.10
The effect of precursors of 5-hydroxytryptamine on gastric secretion in anaesthetized dogs. J Physiol (1959) 1.10
Inhibition of gastric acid secretion in the dog by the precursor of serotonin, 5-hydroxytryptophan. Gastroenterology (1958) 1.07
Stimulation of prostaglandin production in rabbit ileal mucosa by bradykinin. J Pharmacol Exp Ther (1983) 1.07
Role of hepatic arterial embolisation in the carcinoid syndrome. Br Med J (Clin Res Ed) (1983) 1.05
Synthesis and metabolism of endogenous prostaglandins by human gastric mucosa. Adv Prostaglandin Thromboxane Res (1980) 0.94
Prostaglandins as mediators of paraneoplastic syndromes: review and up-date. Metabolism (1981) 0.92
Prostaglandins E and F in endocrine diarrheagenic syndromes. Ann Surg (1976) 0.89
Serum prostaglandin F-2 alpha concentration in the carcinoid syndrome. Prostaglandins (1974) 0.88
The effect of intravenous infusions of prostaglandins E-2 and F-2alpha on human gastric function. Gut (1975) 0.86
Colonic secretion mediated by prostaglandin E2 and 5-hydroxytryptamine may contribute to diarrhea due to morphine withdrawal in the rat. Gastroenterology (1984) 0.79
Both topical and systemic treatments with 16,16-dimethyl prostaglandin E2 are trophic to rat gastric mucosa. Scand J Gastroenterol Suppl (1984) 0.78
Oral antisecretory activity of prostaglandin E2 in man. Dig Dis Sci (1984) 0.77
Methylated analogues of prostaglandin E2 and the gastric mucosal barrier. Prostaglandins (1978) 0.77
Prostaglandin E generation during storage of plasma samples. Prostaglandins (1974) 0.77
16,16-Dimethyl prostaglandin E2 stimulates growth and maturation of rat gastric and small-intestinal mucosa. Scand J Gastroenterol Suppl (1984) 0.77
Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature (2000) 8.96
Unbuffered highly acidic gastric juice exists at the gastroesophageal junction after a meal. Gastroenterology (2001) 3.52
Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease. Gastroenterology (1995) 3.28
Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology (1997) 3.16
Alosetron in irritable bowel syndrome. Lancet (2000) 2.94
Does concern about missing malignancy justify endoscopy in uncomplicated dyspepsia in patients aged less than 55? Am J Gastroenterol (1999) 2.89
Quantitative analysis of changes in ER, PR and HER2 expression in primary breast cancer and paired nodal metastases. Ann Oncol (2009) 2.65
Rebound hypersecretion after omeprazole and its relation to on-treatment acid suppression and Helicobacter pylori status. Gastroenterology (1999) 2.53
The Glasgow Dyspepsia Severity Score--a tool for the global measurement of dyspepsia. Eur J Gastroenterol Hepatol (1996) 2.19
Eradicating Helicobacter pylori infection lowers gastrin mediated acid secretion by two thirds in patients with duodenal ulcer. Gut (1993) 2.05
Tin protoporphyrin prolongs the biochemical remission produced by heme arginate in acute hepatic porphyria. Gastroenterology (1993) 1.76
Controlled trial of haem arginate in acute hepatic porphyria. Lancet (1989) 1.75
Increased prevalence of precancerous changes in relatives of gastric cancer patients: critical role of H. pylori. Gastroenterology (2000) 1.74
The role of interleukin-1 polymorphisms in the pathogenesis of gastric cancer. Nature (2001) 1.71
Association between antibodies to heat shock protein 65 and coronary atherosclerosis. Possible mechanism of action of Helicobacter pylori and other bacterial infections in increasing cardiovascular risk. Eur Heart J (1998) 1.71
Lowered gastrin and gastric acidity after eradication of Campylobacter pylori in duodenal ulcer. Lancet (1989) 1.70
Effect of increasing Helicobacter pylori ammonia production by urea infusion on plasma gastrin concentrations. Gut (1991) 1.66
Acute perforated duodenal ulcer is not associated with Helicobacter pylori infection. Gut (1993) 1.64
Helicobacter pylori infection and coronary heart disease in the North Glasgow MONICA population. Eur Heart J (1997) 1.60
Plasma gastrin concentrations are normal in patients with colorectal neoplasia and unaltered following tumor resection. Gastroenterology (1994) 1.50
Helicobacter pylori infection potentiates the inhibition of gastric acid secretion by omeprazole. Gut (1999) 1.50
The ethics of difficult tracheal intubation. Anaesthesia (1988) 1.41
Comment on article by Oksüzoglu et al. Endoscopy (1998) 1.37
Comparison of gastric body and antral pH: a 24 hour ambulatory study in healthy volunteers. Gut (1989) 1.33
Omeprazole, Helicobacter pylori status, and alterations in the intragastric milieu facilitating bacterial N-nitrosation. Gastroenterology (2000) 1.33
Detection of Helicobacter pylori infection of the gastric mucosa by measurement of gastric aspirate ammonium and urea concentrations. Gut (1991) 1.31
Treatment with haematin in acute hepatic porphyria. Q J Med (1981) 1.29
Low prevalence of Helicobacter pylori in inflammatory bowel disease: association with sulphasalazine. Gut (1994) 1.28
Helicobacter pylori utilises urea for amino acid synthesis. FEMS Immunol Med Microbiol (1996) 1.26
Rebound nocturnal hypersecretion after four weeks treatment with an H2 receptor antagonist. Gut (1989) 1.23
The mammalian target of rapamycin inhibitor everolimus (RAD001) in early breast cancer: results of a pre-operative study. Breast Cancer Res Treat (2010) 1.21
Induction of delta-aminolaevulinic acid synthase in leucocytes of patients on phenytoin therapy--comparison with changes in rat hepatic tissue. Br J Clin Pharmacol (1980) 1.19
Effect of Helicobacter pylori and its eradication on gastric juice ascorbic acid. Gut (1994) 1.19
Effects of cimetidine on carbamazepine auto- and hetero-induction in man. Br J Clin Pharmacol (1984) 1.19
Acute amiodarone-induced lung toxicity. Intensive Care Med (1998) 1.18
Screening for latent acute intermittent porphyria: the value of measuring both leucocyte delta-aminolaevulinic acid synthase and erythrocyte uroporphyrinogen-1-synthase activities. J Med Genet (1982) 1.15
Effect of Helicobacter pylori on parietal cell sensitivity to pentagastrin in duodenal ulcer subjects. Scand J Gastroenterol (1992) 1.14
Effect of inhibition of Helicobacter pylori urease activity by acetohydroxamic acid on serum gastrin in duodenal ulcer subjects. Gut (1991) 1.13
Sucralfate suppresses Helicobacter pylori infection and reduces gastric acid secretion by 50% in patients with duodenal ulcer. Gastroenterology (1996) 1.12
The acid response to gastrin distinguishes duodenal ulcer patients from Helicobacter pylori-infected healthy subjects. Gastroenterology (1998) 1.12
Detection of resistance due to inducible beta-lactamase in Enterobacter aerogenes and Enterobacter cloacae. J Clin Microbiol (1994) 1.11
Does concern about missing malignancy justify endoscopy in uncomplicated dyspepsia in patients aged less than 55? Am J Gastroenterol (1999) 1.10
The porphyrias: an example of pharmacogenetic disease. Scott Med J (1981) 1.09
Eradication of Helicobacter pylori: an objective assessment of current therapies. Br J Clin Pharmacol (1997) 1.08
The magic nature of (132)Sn explored through the single-particle states of (133)Sn. Nature (2010) 1.07
Electrodes for 24 hours pH monitoring--a comparative study. Gut (1987) 1.06
A substantial proportion of non-ulcer dyspepsia patients have the same abnormality of acid secretion as duodenal ulcer patients. Gut (1995) 1.05
Effect of Helicobacter pylori infection on intragastric urea and ammonium concentrations in patients with chronic renal failure. J Clin Pathol (1993) 1.04
A combined TDDA-PVC pH and reference electrode for use in the upper small intestine. J Med Eng Technol (1990) 1.04
Helicobacter pylori related hypergastrinaemia is the result of a selective increase in gastrin 17. Gut (1993) 1.04
Omeprazole and dietary nitrate independently affect levels of vitamin C and nitrite in gastric juice. Gastroenterology (1999) 1.03
Is Helicobacter pylori associated hypergastrinaemia due to the bacterium's urease activity or the antral gastritis? Gut (1991) 1.02
Metastatic pulmonary ameloblastoma. An unusual case. Br J Oral Maxillofac Surg (2003) 1.02
Effect of Helicobacter pylori on serum pepsinogen I and plasma gastrin in duodenal ulcer patients. Scand J Gastroenterol (1992) 1.01
Comparison of helisal rapid blood test and 14C-urea breath test in determining Helicobacter pylori status and predicting ulcer disease in dyspeptic patients. Am J Gastroenterol (1998) 0.99
Effect of rifampicin on haem and bilirubin metabolism in man. Br J Clin Pharmacol (1987) 0.98
Evaluation of an automated fluorescent treponemal antibody test for syphilis. Br J Vener Dis (1970) 0.98
Familial hyperthyroidism without evidence of autoimmunity. Acta Endocrinol (Copenh) (1982) 0.98
Measurement of urea and ammonium concentrations in gastric juice. J Clin Pathol (1993) 0.96
Harnessing of urease activity of Helicobacter pylori to induce self-destruction of the bacterium. J Clin Pathol (1991) 0.95
Comparison of an enzyme immunoassay for the detection of Helicobacter pylori antigens in the faeces with the urea breath test. Arch Dis Child (2000) 0.93
Neurone specific enolase (NSE) in small cell lung cancer: a tumour marker of prognostic significance? Br J Cancer (1990) 0.92
Seasonal abundance of aphids (Homoptera: Aphididae) in wheat and their role as barley yellow dwarf virus vectors in the South Carolina coastal plain. J Econ Entomol (2001) 0.92
Acute ethanol ingestion and haem biosynthesis in healthy subjects. Eur J Clin Invest (1980) 0.92
Alterations in haem biosynthesis during the human menstrual cycle: studies in normal subjects and patients with latent and active acute intermittent porphyria. Clin Sci (Lond) (1982) 0.92
Chromosome instability and benefit from adjuvant anthracyclines in breast cancer. Br J Cancer (2012) 0.92
Helicobacter pylori-related hypergastrinaemia is not due to elevated antral surface pH. Studies with antral alkalinisation. Scand J Gastroenterol (1992) 0.91
Pyrbuterol: a new bronchodilator. Phase I-single dose study. Curr Ther Res Clin Exp (1974) 0.91
Hemorrhagic diathesis associated with a hereditary platelet disorder in Simmental cattle. J Vet Diagn Invest (1993) 0.91
In vitro studies indicate that acid catalysed generation of N-nitrosocompounds from dietary nitrate will be maximal at the gastro-oesophageal junction and cardia. Scand J Gastroenterol (2002) 0.91
Role of ammonia in the pathogenesis of the gastritis, hypergastrinaemia, and hyperpepsinogenaemia I caused by Helicobacter pylori infection. Gut (1992) 0.90
Bronchodilator, cardiovascular, and cyclic guanylyl monophosphate response to high-dose infused atrial natriuretic peptide in asthma. Am Rev Respir Dis (1993) 0.90
Effect of atrial natriuretic peptide given by intravenous infusion on bronchoconstriction induced by ultrasonically nebulized distilled water (fog). Am Rev Respir Dis (1992) 0.90
Early-onset chronic renal failure as a complication of acute intermittent porphyria. Q J Med (1983) 0.90
The acute porphyrias. Br J Clin Pract (1993) 0.89
Lack of certainty on the diagnosis of acute intermittent porphyria: comment on the concise communication by Cohen et al. Arthritis Rheum (1998) 0.89
Smoking and recurrent attacks of acute intermittent porphyria. BMJ (1991) 0.88
Effects of a lifting belt on spine moments and muscle recruitments after unexpected sudden loading. Spine (Phila Pa 1976) (2000) 0.88
Gall bladder emptying in normal subjects--a data base for clinical cholescintigraphy. Gut (1987) 0.88
Activity of the renin-angiotensin system in acute severe asthma and the effect of angiotensin II on lung function. Thorax (1994) 0.88
Problems associated with the clinical use of proton pump inhibitors. Pharmacol Toxicol (2001) 0.87
Helicobacter pylori in the faeces? QJM (1999) 0.86
Changes in PIK3CA mutation status are not associated with recurrence, metastatic disease or progression in endocrine-treated breast cancer. Breast Cancer Res Treat (2014) 0.86
A manipulandum for human motor studies. IEEE Trans Biomed Eng (1976) 0.86
Chester porphyria: biochemical studies of a new form of acute porphyria. Lancet (1985) 0.86
Suicidal destruction of Helicobacter pylori: metabolic consequence of intracellular accumulation of ammonia. J Clin Pathol (1991) 0.86
Alcohol and porphyria. Lancet (1981) 0.85
A primary platelet disorder of consanguineous simmental cattle. Thromb Res (1993) 0.85
Eradication of Helicobacter pylori in functional dyspepsia. Study had several weaknesses. BMJ (1999) 0.85
Forearm oscillation during cooling of the dentate mucleus in the monkey. Can J Physiol Pharmacol (1976) 0.85
Management of recurrent malignant pleural effusion in the United Kingdom: survey of clinical practice. Thorax (1990) 0.83
Gastric cancer in patients with benign dyspepsia. Gut (2001) 0.83
Facility of motor unit control during tasks defined directly in terms of unit behaviors. Exp Neurol (1978) 0.83
Hypertension and renal impairment as complications of acute porphyria. Nephrol Dial Transplant (1992) 0.83
Management of attacks of acute porphyria. Drugs (1987) 0.83
The diagnosis of Helicobacter pylori infection in uremic patients. Am J Kidney Dis (1992) 0.83
The rater reliability of assessments of symptom provocation in patients with low back pain. J Back Musculoskelet Rehabil (2002) 0.83
Enterogastric reflux and gastric clearance of refluxate in normal subjects and in patients with and without bile vomiting following peptic ulcer surgery. Ann Surg (1986) 0.83
Effect of a single oral dose of enprostil on gastric secretion and gastrin release. Studies in healthy volunteers and patients with pernicious anemia. Am J Med (1986) 0.82
Safety of general anaesthesia and surgery in acute hepatic porphyria. Gut (1994) 0.82